Why Attend
The gut microbiota’s importance in human health and disease progression spreads far wider than just gastro-intestinal conditions. The immune, nervous and metabolic systems couple the microbiome with the rest of the body and play a crucial and interlinking role in extra-intestinal diseases including neurological, cancer and metabolic conditions.
For the 5th annual European Microbiome Congress, we’ve shifted the focus from gastro-intestinal to extra-intestinal as we examine the latest pre-clinical and clinical data demonstrating the gut microbiota’s role in some of the world’s most critical and costly diseases in modern society.
Join key opinion leaders from across academia and industry to examine the latest research data. This is your opportunity to find outhow others plan to translate the latest understanding of the gut-microbiome into therapeutic drugs that have the power to treat
cancer, metabolic, neurodegenerative and psychiatric disorders.
Submit your poster
Looking to showcase your recent work to the microbiome community?
Our dedicated poster area is the perfect way to get your research noticed and further involve yourself in the congress. In order to present a poster at the forum you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).
At the Congress, your presentation will be displayed in a dedicated poster area which can be viewed during the networking break.
Series Highlights
Who Will Be There
-
Academics50%
-
Biotech20%
-
Pharma & Food Companies20%
-
Investors10%
Speakers
Adrien Nivoliez
Aletta Kraneveld
In 2016 Aletta Kraneveld (MSc Pharmacy & pharmacologist) was appointed as full professor Interdisciplinary Translational Pharmacology at the Faculty of Science and the Faculty of Veterinary Medicine of the Utrecht University. She has published >120 papers (H-index: 42). Besides science, she is/has been an active member of several boards of (inter)national scientific and societal organizations (Dutch Society of Pharmacology, EPHAR, IUPHAR, Netherlands Federation of Innovative Drug research; Diversity committee UU; Food Lives-NL).
Kraneveld’s current research interests involve targeting the interaction between innate and adaptive immunity as well as host-microbiome interactions in chronic (inflammatory) diseases with pharmaceutical as well as nutritional interventions. The Kraneveld group is focusing research to in depth study the role of the gut-immune-brain-axis in neurodevelopmental and neurodegenerative disorders. Results will further enhance the knowledge of the interaction of microbiome with the immune and nervous systems in chronic conditions in the gut and CNS. Aletta Kraneveld has set up a program that is a (inter)national neuro-immune platform where academia, patient organisations and industry meet for research on the gut-immune-brain axis as target for medicine and medical food concepts.
Andrew Morgan
Dr Andrew Morgan is Chair of the UK’s KTN Microbiome Special Interest Group and has close to 40 years’ experience in health & nutrition research & innovation related to microbe-host interactions including human, animal and plant. He held the role of Chief Scientist to DuPont’s Nutrition & Health and legacy Danisco business (2008-2019) and was a DuPont Fellow. Having joined the company as a member of the pioneering FFI animal nutrition enzyme team, he then went on to play a key role in helping build DuPont’s microbiome platform. Andrew retired from DuPont at the end of 2019.
Anna Ettore
Isabelle de Cremoux
Benno Haarman
Alongside continuing efforts to elucidate the pathophysiology of bipolar disorder, Dr. Haarman’s research currently focuses on the treatment of this severe psychiatric illness using immune modulating, psychosurgical and chronobiological therapies. In the field of psycho-immunology he is performing treatment studies in bipolar disorder using probiotics, diets and spinning.
Benoit Levast
Christopher Reyes
Georg Zeller
Grégory Lambert
Pharmacist and Ph.D. in pharmaceutical technology, Gregory’s carrier is split between Biotech and Pharma where he occupied the positions of Chief Scientific Officer and Chief Executive Officer. Gregory drove the development of a number of drugs, medical devices and food supplement from the laboratory to market. Since 2014, Gregory is the CEO of TargEDys.
Imke Mulder
Ben Mullish
Dr James Kinross
Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital London. His clinical interests are in minimally invasive and laparoscopic surgery for the treatment of colorectal cancer. He also has an interest in surgical nutrition and modulation of the gut microbiota by pro and prebiotics for improved operative outcomes. He was trained in Northwest London, and he was an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery. He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer. He is a visiting Professor at the Royal College of Surgeons of Ireland. He is currently funded by Bowel and Cancer research and the Imperial BRC.
James McIlroy
Jos Seegers
Karine Clement
Laura Steenbergen
Morten Isaksen
Nader Yaghoubi
Patrice Garnier
Paul Wilmes
Robert Jan Brummer
Robert JM Brummer is professor of Gastroenterology and Clinical Nutrition and senior consultant at Örebro University and University Hospital, Sweden. He is director of the interdisciplinary Nutrition-Gut-Brain Research Centre as well as the national research excellence centre PAN Sweden (Plant-based Proteins for Health and Well-being). As Pro-Vice-Chancellor of the University he leads the University Food and Health Strategic Programme that comprises all Faculties and Schools of the University. Brummer is engaged in (inter)national boards and strategies regarding food and nutrition research and innovation and acts as reviewer for several international research councils.
Arne Materna Ph.D
Shahram Lavasani
Dr. Shahram Lavasani is an international keynote speaker and entrepreneur in the field of the microbiome. He received his PhD in Immunology from Lund University/Sweden. With more than two decades of teaching and research expertise on Gut-Brain axis, he has pioneered research in multiple sclerosis by demonstrating gut inflammation and barrier dysfunction and introduced microbiota-based therapies using probiotic bacterial consortia. He is the founder of ImmuneBiotech developing novel microbiome therapeutics. The company has access to a proprietary lactobacilli library and advanced selection technologies to design nutritional formulations for optimal management of the diseases. ImmuneBiotech´s first product GutMagnific® has been designed to address the underlying causes of IBS and it is currently investigated, in collaboration with Karolinska Institute, for treatment of chronic fatigue syndrome (ME/CFS) a neuroimmune condition and a possible long-term effect of Covid-19. GutMagnific® has successfully been launched in October 2019.
Yolanda Sanz Herranz
Dr. Henrik Bjørn Nielsen
Ravi Starzl
Dr. Machteld Tiemessen
In July 2018, Dr. Machteld Tiemessen joined Danone Nutricia Research as Team Leader Immunology in the Global Center of Excellence Immunology. Since obtaining her PhD in Immunology in 2004, which was focused on the induction of oral tolerance in food allergy, she has held many different positions, both at academia and in industry. The main topic at the start of her career was the investigation of the role and mechanisms of regulatory T cells in normal immune responses and during diseases, such as allergy and cutaneous T cell lymphoma. In 2010, she received a Veni-grant to further elucidate the role of Wnt-signaling in peripheral T cell function (not restricted to regulatory T cells). After 14 years of research at several universities in The Netherlands and King’s College in London, the United Kingdom, she started in 2013 at Johnson & Johnson to apply her immunological knowledge in the field of viral vaccines. At J&J, she led various discovery projects, with a focus on early discovery projects in the field of oncology vaccines and in the field of polio vaccines.
Associate Event Partner
Thought Leadership Partner
Event Partners
Media Partners
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
The Agenda
We're excited to share that the agenda for the 5th annual European Microbiome Congress is now live. To find out what you can expect onsite, please download the agenda.
NEW FOR 2019:
The gut microbiota has been proven to be a viable drug target for gastro-intestinal diseases such as IBD, Crohns and Colitis - however, there is growing (pre)clinical data to translate findings from the gut microbiome to extra-intestinal conditions. This year, we will explore beyond the gut and focus on 3 major topics:
Gut-brain axis
Microbiome-oncology
Microbiome and metabolic diseases
Download Agenda
Venue
Olympia London, Hammersmith Rd, London W14 8UX
Hilton London Olympia, 380 Kensington High Street, London W14 8NL (0.2miles from the Olympia Conference Centre)
Rate: £215 includes VAT including English breakfast, single occupancy
Book online: http://eventsathilton.com/show/5cacc48e2322ec7c5fd65560
Book by 18th October 2019.
The Copthorne Tara Hotel, Scarsdale Place, London, W8 5SR (1.0mile from Olympia Conference Centre)
Rate per night: £130 includes VAT and breakfast, single occupancy
Call reservations + 44 (0) 207 872 2000
Email:[email protected]
Quote code GA1L121119 when booking
Book by 22nd October 2019.
Ibis Earl’s Court Hotel, 47 Lillie Road, Fulham, London, SW6 1UD (1.0mile from the Olympia Conference Centre)
Rate: £99 includes VAT and breakfast, single occupancy
Email: Email Enrico in reservations on [email protected]
Phone: Enrico on +44(0) 207 666 8495
Quote booking code KISACO121119-1 when booking.
Book by 15th October 2019.
K West Hotel & SpaRichmond Way, London W14 0AX
Rate: £190.00 inclusive of VAT and Continental breakfast (single occupancy), per room, per night.
- Individual cancellation policy 7 days prior to arrival.
Contact Rezo on: +44(0)20 8008 6605
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
Thank You
Thanks for registering your interest in the Metabolon Evening Seminar.